Libre 3 path to Medicare coverage
Abbott has received Food and Drug Administration (FDA) clearance for a reader for its newest continuous glucose monitoring (CGM) system in the USA. Its FreeStyle
Abbott has received Food and Drug Administration (FDA) clearance for a reader for its newest continuous glucose monitoring (CGM) system in the USA. Its FreeStyle
New research has revealed that taking short breaks from sitting can help people with Type 1 diabetes better manage their blood sugar levels. Sitting for
An investigational outpatient endoscopic procedure may help eliminate the need for insulin in people with Type 2 diabetes, early research suggests. Called re-cellularization via electroporation
Embecta, the largest maker of disposable pen needles and insulin syringes for people withy diabetes, has announced plans to develop its own insulin pump, signaling
Innovation Zed, a company based in Ireland, specialises in the development of innovative medical devices. It has partnered with GluCare.Health, a leading metabolic disease management
Medtronic has begun working with computer chip maker Nvidia on a platform for artificial intelligence applications to run on its medical devices. The companies hope
Sernova Corp has announced that the first two patients in the second cohort of its active U.S. Phase 1/2 clinical trial for the treatment of
A study has been conducted to explore the possible association between vitamin B12 deficiency and gastroparesis in patients with Type 2 diabetes. Diabetic gastroparesis is
According to DiaTribe Learn, Novo Nordisk has released initial results for a clinical trial testing Rybelsus at high doses, showing significant reductions in both HbA1c
Soft drinks are considered as drivers for obesity and Type 2 diabetes, but little progress is being made in reducing sugar in soft drinks. From